Frontiers in Drug Delivery - Bias and Credibility

Frontiers in Drug Delivery – is rated PRO-SCIENCE with MOSTLY FACTUAL factual reporting and High Credibility by Media Bias Fact Check.

PRO-SCIENCE

These sources consist of legitimate science or are evidence-based through credible scientific sourcing. Legitimate science follows the scientific method, is unbiased, and does not use emotional words. These sources also respect the consensus of experts in the given scientific field and strive to publish peer-reviewed science. Some sources in this category may have a slight political bias but adhere to scientific principles. See all Pro-Science sources.

Overall, we rate Frontiers in Drug Delivery as a Pro-Science journal based on peer review and a clean fact-check record. We also rate them Mostly Factual due to Frontier Media’s retractions of studies either pre or post-publication.

Detailed Report

Bias Rating: PRO-SCIENCE
Factual Reporting: MOSTLY FACTUAL
Country: Ireland
MBFC’s Country Freedom Rating: EXCELLENT
Media Type: Journal
Traffic/Popularity: Minimal Traffic
MBFC Credibility Rating: HIGH CREDIBILITY

History

Frontiers in Drug Delivery is a peer-reviewed open-access journal that covers Drug Delivery. According to its About page, “Frontiers in Drug Delivery is a multidisciplinary, DOAJ-indexed journal that focuses on drug delivery concepts at a cell and tissue level, through to translational outcomes in preclinical and clinical studies for drug formulations and formulations combined with devices.”

Read our profile on the UK’s media and government.

Funded by / Ownership

Frontiers in Drug Delivery is owned by Frontiers Media SA, which is a for-profit corporation. Funding comes from digital sales of content and author fees for publication.

Analysis / Bias

Frontiers in Drug Delivery is an open-access journal that publishes information and research related to Drug Delivery. The journal primarily publishes research like this: Release of delta-9-tetrahydrocannabinol from polyvinyl alcohol hydrogels and its safe interaction with human skin fibroblasts.

Frontiers Media has been criticized for being a predatory open-access publisher. In short, Predatory Open Access publishing is an exploitative open-access publishing business model that involves charging publication fees to authors without providing the editorial and publishing services associated with legitimate journals.

However, Frontiers in Drug Delivery is a credible scientific journal, as we have not found any controversy or significant retractions. However, Frontiers Media has retracted some studies in other publications that were found to be of poor methodology and not thoroughly peer-reviewed.

Failed Fact Checks

None to date

Overall, we rate Frontiers in Drug Delivery as a Pro-Science journal based on peer review and a clean fact-check record. We also rate them Mostly Factual due to Frontier Media’s retractions of studies either pre or post-publication. (D. Van Zandt 01/16/2024)

Source: https://www.frontiersin.org/journals/drug-delivery

Last Updated on January 16, 2024 by Media Bias Fact Check